We also understand the innovation landscape can be overwhelming. How do you separate out proven ideas that work from the hype?
With so many new innovations and processes competing for your attention, we can help you focus on the evidence backed programmes which have been identified by the NHS for national adoption and spread because of their potential for large impact.
We deliver the roll out of nationally driven programmes, including patient safety programmes, Rapid Uptake Products from the NHS Accelerated Access Collaborative and innovations selected by NHS England as part of the Innovation and Technology Payment (ITP) programme. We are a trusted partner to the NHS, to practically support you to adopt and spread these proven innovations and help deliver a lasting legacy for health and care across our region.
Help us understand your challenges so that we can look to match your problems with applicable solutions. If you work in healthcare and have a challenge that requires fresh thinking, let us know and we will do our best to help you.
We also know that a great idea can take many forms and some of the best ideas come from those who are experienced in the delivery of care:
As we live in the largest life sciences cluster in Europe and have the most brilliant health and care practitioners in the world, we also want our community to benefit from both, creating better health outcomes and more prosperity by enabling clinical teams to share their views with innovators and vice versa.
Part of our role is therefore also to encourage our ecosystem to work together and support clinical entrepreneurs with ideas to transform health and care. If you have an idea, please also check out our page for innovators.
Our patient safety team is funded and co-ordinated by NHS England and NHS Improvement to play a critical role in identifying and spreading safer care initiatives across our region.
We do this by working across acute, non-acute and community settings to quickly share and spread evidence-based practices, products and tools.
We are focused on the following national priority areas:
Failure to identify and respond to the deterioration of a patient’s condition can lead to delays in care and in some cases, patient harm. To get the best outcomes for patients who may be at risk of, or are experiencing physical deterioration in acute and community settings, we work with organisations to support the testing of tools to standardise the identification of a deteriorating patient, such as NEWS2 and spotting the ‘soft signs’ of deterioration. It is also important to have the right response and escalation once a deteriorating patient is identified and we are testing these with stakeholders including SBAR and safety huddles.
COVID Oximetry at Home Programme (virtual ward)
The COVID Oximetry at Home programme (sometimes called a virtual ward) describes an enhanced package of care for individuals with confirmed or suspected COVID-19 who are at risk for future deterioration, including both patients living in their own homes and residents of care homes. The AHSN Network is supporting the uptake of this package through the Patient Safety Collaboratives in each region. Find out more here.
Emergency laparotomy care bundle
An emergency laparotomy is a surgical operation that is used for people with severe abdominal pain, to find the cause of the problem and where possible treat it. As it is an emergency procedure, complications are common. The laparotomy six-part care bundle is designed for acute trusts and has been proven to reduce mortality rates and reduce length of stay.
COPD discharge care bundle
We are embedding the chronic obstructive pulmonary disease (COPD) discharge care bundle across acute trusts in our region. The bundle describes five high impact actions to ensure the best clinical outcome for patients admitted with an acute exacerbation as a result of COPD. The aim is to reduce the number of patients who are readmitted following discharge after an acute exacerbation and to ensure that all aspects of the patient’s care are considered.
Maternity and Neonatal Safety Improvement Programme
The Maternity And Neonatal Safety Improvement Programme is a national programme delivered locally in partnership to:
Preterm birth is the leading cause of brain injury and cerebral palsy, which can have a lifelong impact on children and families. PReCePT, which stands for the Prevention of Cerebral Palsy in PreTerm Labour, has been designed to help prevent cerebral palsy in babies by administering magnesium sulphate (MgSO4) to mothers during preterm labour. We have successfully supported the uptake of magnesium sulphate for pre-term mothers under 30 weeks in every maternity unit in our region.
Medicines Safety Improvement Programme
Our Medicines Safety Improvement Programme (MedSIP) aims to reduce errors in the administration of medicines in care homes, to improve the safety and experience of care. Our work includes mapping out what is working around medicines safety in care homes, exploring the nature and scale of medication errors and assessing the quality improvement capabilities of care home staff. This allows us to understand current delivery processes, in addition to the nature and scale of any issues so that we can support improvement interventions.
Good ideas, combined with the right direction and a culture of learning, can save lives.
Tell us about the challenges you face when delivering health and care services.Get involved